Matching the right chemotherapy to the right patient.

Cancer is not a single disease. Every cancer is unique, derived from the genetics of the individual combined with the particular mutations that drive the malignancy. 

Imagen Therapeutics’ predictRx test measures the effectiveness of a range of available chemotherapy drugs in killing a cancer sample derived from a patient.  The test is based on automated fluorescence microscopy (High Content Analysis) in conjunction with automated cell seeding and drug dosing.

DSC6970

Imagen Therapeutics uses a phenotypic approach to measure the effectiveness of a wide range of available chemotherapy drugs.